Literature DB >> 16261302

Fatal varicella zoster virus infection as first manifestation of idiopathic CD4+ T-cell lymphocytopenia.

K Hochauf1, D Bandt, C Pöhlmann, S Monecke, M Toma, S Trautmann.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16261302     DOI: 10.1007/s10096-005-0033-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  10 in total

1.  Idiopathic CD4+ T lymphocytopenia in two siblings.

Authors:  S J Lin; H C Chao; D C Yan; M L Kuo
Journal:  Pediatr Hematol Oncol       Date:  2001-03       Impact factor: 1.969

2.  Lymphocyte diversity in a 9-year-old boy with idiopathic CD4+ T cell lymphocytopenia.

Authors:  M Frühwirth; K Clodi; A Heitger; N Neu
Journal:  Int Arch Allergy Immunol       Date:  2001-05       Impact factor: 2.749

3.  Rapid genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolates using miniaturised oligonucleotide arrays.

Authors:  S Monecke; R Ehricht
Journal:  Clin Microbiol Infect       Date:  2005-10       Impact factor: 8.067

4.  Successful IL-2 therapy for relapsing herpes zoster infection in a patient with idiopathic CD4+ T lymphocytopenia.

Authors:  K Warnatz; R Draeger; M Schlesier; H H Peter
Journal:  Immunobiology       Date:  2000-08       Impact factor: 3.144

5.  Cutaneous infections by papillomavirus, herpes zoster and Candida albicans as the only manifestation of idiopathic CD4+ T lymphocytopenia.

Authors:  P Manchado Lopez; J M Ruiz de Morales; I Ruiz González; M A Rodriguez Prieto
Journal:  Int J Dermatol       Date:  1999-02       Impact factor: 2.736

6.  Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia.

Authors:  S R Pevenstein; R K Williams; D McChesney; E K Mont; J E Smialek; S E Straus
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 7.  Progressive multifocal leukoencephalopathy and idiopathic CD4+lymphocytopenia: a case report and review of reported cases.

Authors:  S Haider; D Nafziger; J A Gutierrez; I Brar; N Mateo; J Fogle
Journal:  Clin Infect Dis       Date:  2000-10       Impact factor: 9.079

Review 8.  Primary aspergillosis of the larynx associated with CD4+ T lymphocytopenia.

Authors:  Mitsuhiko Nakahira; Shuji Matsumoto; Naoko Mukushita; Hiroaki Nakatani
Journal:  J Laryngol Otol       Date:  2002-04       Impact factor: 1.469

9.  Idiopathic CD4+ T-lymphocytopenia--an analysis of five patients with unexplained opportunistic infections.

Authors:  T J Spira; B M Jones; J K Nicholson; R B Lal; T Rowe; A C Mawle; C B Lauter; J A Shulman; R A Monson
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

Review 10.  Idiopathic CD4+ T cell lymphocytopenia with the absence of B cells and CD8+28+ cells in peripheral blood.

Authors:  N Kutukculer; G Aksu; F Genel; C Ozturk
Journal:  Clin Exp Med       Date:  2002-11       Impact factor: 3.984

  10 in total
  3 in total

1.  Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia.

Authors:  Virginia Sheikh; Brian O Porter; Rebecca DerSimonian; Stephen B Kovacs; William L Thompson; Ainhoa Perez-Diez; Alexandra F Freeman; Gregg Roby; JoAnn Mican; Alice Pau; Adam Rupert; Joseph Adelsberger; Jeanette Higgins; Jeffrey S Bourgeois; Stig M R Jensen; David R Morcock; Peter D Burbelo; Leah Osnos; Irina Maric; Ven Natarajan; Therese Croughs; Michael D Yao; Jacob D Estes; Irini Sereti
Journal:  Blood       Date:  2015-12-16       Impact factor: 22.113

2.  Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases.

Authors:  Dina S Ahmad; Mohammad Esmadi; William C Steinmann
Journal:  Avicenna J Med       Date:  2013-04

Review 3.  Complicated Varicella Infection at 8-year-old Boy with Pulmonary Agenesis.

Authors:  Meliha Hadzovic-Cengic; Rusmir Baljic; Amir Hadzic; Enra Lukovac; Snjezana Mehanic; Aida Ahmetspahic-Begic
Journal:  Mater Sociomed       Date:  2012
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.